{"title": "Potential therapeutic target for amyotrophic lateral sclerosis", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/stem_cells.xml", "value": "Potential therapeutic target for amyotrophic lateral sclerosis"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/01/190115162311.htm"}], "link": "https://www.sciencedaily.com/releases/2019/01/190115162311.htm", "summary": "New research has revealed that the protein TDP-43 regulates a gene called Stathmin2 (STMN2). STMN2 shows promise as a therapeutic target and could be the first biomarker ALS, which is extremely difficult to diagnose and treat.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/stem_cells.xml", "value": "New research has revealed that the protein TDP-43 regulates a gene called Stathmin2 (STMN2). STMN2 shows promise as a therapeutic target and could be the first biomarker ALS, which is extremely difficult to diagnose and treat."}, "media_thumbnail": [{"url": "https://www.sciencedaily.com/images/2019/01/190115162311-large.jpg", "height": "169", "width": "300"}], "href": "", "published": "Tue, 15 Jan 2019 16:23:11 EST", "published_parsed": [2019, 1, 15, 21, 23, 11, 1, 15, 0], "id": "https://www.sciencedaily.com/releases/2019/01/190115162311.htm", "guidislink": false}